⚖

Compare Funds

See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.

CR
Canara Robeco MFCanara Robeco Large and Mid Cap Fund - Growth - Direct PlanDirect · Growth
₹282.16 as on 30 Oct 2026
VS
HD
HDFC MFHDFC Pharma and Healthcare Fund - Growth - Direct PlanDirect · Growth
₹21.95 as on 30 Oct 2026
▤Key Metrics Comparison
MetricCRCanara Robeco Large and Mid Cap Fund - Growth - Direct PlanHDHDFC Pharma and Healthcare Fund - Growth - Direct Plan
Snapshot
AMCCanara Robeco MFHDFC MF
CategoryEquity - Large & Mid Cap FundEquity - Sectoral Fund - Pharma & Health Care
NAV₹282.16 (30 Oct 2026)₹21.95 (30 Oct 2026)
Rating★★★★★★★★
BenchmarkNIFTY LargeMidcap 250 - TRIBSE Health Care - TRI
Fund ManagerAmit NadekarNikhil Mathur
Inception01 Jan 201304 Oct 2023
Returns
1Y-5.65%22.64%
3Y12.61%30.41%
5Y9.53%—
Since Inception18.31%29.15%
Risk
15.0914.07
1.000.59
0.401.59
0.7921.67
0.753.48
-10.75%-9.23%
Costs
Expense Ratio0.77%1.03%
Exit Load1% on or before 1Y, Nil after 1Y1% on or before 30D, Nil after 30D
Min SIP₹1,000₹100
Min Lumpsum₹5,000₹100
Lock-inNoneNone

Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.

◐Portfolio Overlap
Canara Robeco…100%
HDFC MF100%
0.0%

Only 0.0% of holdings by weight are common between Canara Robeco MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.

Category context: Equity vs Equity. Open the full Screener →